Treatment effect of Yinzhiku on rats with hepatic fibrosis
JI Yu-bin
Abstract
JI Yu-bin
Abstract
To investigate the effects of compound Yinzhiku on hepatic fibrosis in rats. The expression of mRNA and proteins of TGF-β1, MMP-13 and TIMP-1 were detected by RT-PCR and immunohistochemistry after liver fibrosis. The levels of mRNA and protein of TGF-β1 and TIMP-1 in liver were significantly reduced in effective dosage, but the levels of mRNA and protein of MMP- 13 in liver significantly increased in effective dosage. The results showed that compound Yinzhiku has significantly inhibit the development of liver fibrosis in rats induced by CCl4.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
To investigate the effects of compound Yinzhiku on hepatic fibrosis in rats. The expression of mRNA and proteins of TGF-β1, MMP-13 and TIMP-1 were detected by RT-PCR and immunohistochemistry after liver fibrosis. The levels of mRNA and protein of TGF-β1 and TIMP-1 in liver were significantly reduced in effective dosage, but the levels of mRNA and protein of MMP- 13 in liver significantly increased in effective dosage. The results showed that compound Yinzhiku has significantly inhibit the development of liver fibrosis in rats induced by CCl4.
Key concepts: Messenger RNA, CCL4, Immunohistochemistry, Hepatic fibrosis, Liver fibrosis, Fibrosis, Internal medicine, Medicine